V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260008630 | 260005746 | null | null | Curative (C) | 2014-05-07 | 2014-06-03 | Rituximab (Maintenance) | null | N | 260028286 | RITUXIMAB |
| 260008631 | 260005747 | null | 60 | Curative (C) | 2017-08-10 | 2017-08-11 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | null | 260028288 | CHLORAMBUCIL |
| 260008632 | 260005748 | 1.75 | 90.7 | Disease modification (D) | 2018-09-22 | 2018-09-30 | CHLORAMBUCIL + RITUXIMAB | N | N | 260028291 | RITUXIMAB |
| 260008633 | 260005749 | 1.65 | 57.4 | Curative (C) | 2016-07-17 | 2016-07-27 | Rituximab (Maintenance) | N | N | 260028294 | BEAM |
| 260008634 | 260005749 | null | 60 | Curative (C) | 2018-06-21 | 2018-06-21 | Hydroxycarbamide | 01 | N | 260028294 | RITUXIMAB |
| 260008635 | 260005750 | 1.72 | 68.2 | null | 2016-10-26 | 2016-11-25 | null | N | N | 260028297 | TRIAL |
| 260008636 | 260005750 | null | 65 | Curative (C) | 2016-09-17 | 2016-09-18 | PACIFICO TRIAL | N | N | 260028297 | BENDAMUSTINE |
| 260008637 | 260005750 | 1.8 | 66.8 | Curative (C) | 2018-08-26 | 2018-09-04 | Irinotecan + Modified De Gramont | 2 | Y | 260028297 | CARBOPLATIN + ETOPOSIDE |
| 260008638 | 260005751 | 1.73 | null | Palliative (P) | 2013-05-15 | 2013-05-20 | null | 2 | N | 260028305 | RITUXIMAB |
| 260008639 | 260005751 | 1.69 | 80.5 | Palliative (P) | 2014-05-23 | 2014-05-23 | Cisplatin + Etoposide (5 day) | 02 | N | 260028305 | RITUXIMAB |
| 260008640 | 260005751 | 1.85 | 67 | Adjuvant (A) | 2014-06-08 | 2014-06-22 | Rituximab | 02 | N | 260028305 | CARBOPLATIN + ETOPOSIDE |
| 260008641 | 260017402 | 1.8 | 108 | Disease modification (D) | 2017-08-29 | 2017-09-14 | DOXORUBICIN + IFOSFAMIDE | N | N | 260028311 | RITUXIMAB |
| 260008642 | 260017402 | null | 82.4 | Disease modification (D) | 2016-01-14 | 2016-01-24 | RCEOP | N | N | 260028311 | RITUXIMAB |
| 260008643 | 260005752 | 1.51 | null | null | 2014-05-07 | 2014-05-09 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 260028314 | BENDAMUSTINE |
| 260008644 | 260005753 | null | null | Disease modification (D) | 2016-07-16 | 2016-07-16 | Rituximab | N | N | 260028315 | RITUXIMAB |
| 260008645 | 260005753 | 1.62 | 70.4 | Disease modification (D) | 2015-01-03 | 2015-01-03 | Rituximab | N | N | 260028315 | RITUXIMAB |
| 260008646 | 260005753 | 1.61 | null | Curative (C) | null | 2016-09-08 | CHOP - 21 days | Y | N | 260028315 | RITUXIMAB |
| 260008647 | 260005754 | 1.8 | 101 | Curative (C) | 2017-07-09 | 2017-07-10 | R-GEM-P | 02 | N | 260028319 | CHOP |
| 260008648 | 260005754 | 1.78 | 70.5 | Curative (C) | 2017-07-05 | 2017-07-20 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 260028319 | BENDAMUSTINE |
| 260008649 | 260005754 | 1.83 | 77 | Curative (C) | 2015-05-16 | 2015-06-21 | RCEOP | 2 | N | 260028319 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260008650 | 260005754 | null | 92 | Palliative (P) | 2016-04-18 | 2016-04-18 | ABVD | 02 | N | 260028319 | DASATINIB |
| 260008651 | 260005755 | 1.65 | 64 | Disease modification (D) | 2015-10-27 | 2016-12-21 | Rituximab | N | N | 260028327 | RITUXIMAB |
| 260008652 | 260011987 | 1.73 | 108.2 | Curative (C) | 2013-04-27 | 2013-04-27 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 260028330 | CAPECITABINE + OXALIPLATIN |
| 260008653 | 260005756 | 1.74 | 84 | Curative (C) | null | 2016-06-16 | Rituximab (Maintenance) | null | null | 260028331 | DOCETAXEL |
| 260008654 | 260005756 | 1.8 | 87.2 | Curative (C) | 2017-12-03 | 2017-12-28 | CYCLO + RITUXIMAB + VINCRISTINE | 2 | Y | 260028331 | RITUXIMAB |
| 260008655 | 260005757 | 1.76 | 79.9 | null | 2015-04-24 | 2015-05-05 | EP 1 2 or 3 day | 2 | N | 260028334 | CVP |
| 260008656 | 260005758 | null | 108 | Curative (C) | 2013-10-12 | 2014-03-23 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260028335 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260008657 | 260011989 | 1.73 | 90 | Palliative (P) | 2017-01-08 | 2017-01-10 | Rituximab (Maintenance) | N | N | 260028340 | BENDAMUSTINE |
| 260008658 | 260011989 | 1.69 | 72 | Curative (C) | 2015-05-18 | 2015-05-26 | Rituximab | N | N | 260028340 | RITUXIMAB |
| 260008659 | 260005759 | 1.69 | 50 | Disease modification (D) | 2013-06-30 | 2013-06-30 | Rituximab | N | N | 260028344 | RITUXIMAB |
| 260008660 | 260005759 | 1.77 | 70 | Curative (C) | 2014-03-26 | 2014-03-27 | GEFITINIB | N | N | 260028344 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260008661 | 260005760 | 1.83 | 70 | Palliative (P) | 2015-04-16 | 2015-04-23 | CHOP - 21 days | N | N | 260028351 | CISPLATIN + GEMCITABINE |
| 260008662 | 260005761 | 1.69 | 76 | Palliative (P) | 2014-03-01 | 2014-03-05 | PACIFICO TRIAL | 02 | null | 260028353 | RITUXIMAB |
| 260008663 | 260005761 | null | 87.1 | Not known (9) | 2015-01-09 | 2015-01-12 | CHOP - 21 days | N | N | 260028353 | PACIFICO TRIAL |
| 260008664 | 260005761 | 1.58 | 56 | Disease modification (D) | 2016-06-21 | 2016-07-02 | Rituximab (Maintenance) | 01 | N | 260028353 | CHLORAMBUCIL |
| 260008665 | 260005762 | 1.77 | 100 | Curative (C) | 2013-09-20 | 2013-09-24 | Triple Intrathecal | 02 | N | 260028361 | RITUXIMAB |
| 260008666 | 260005762 | 1.77 | null | Palliative (P) | null | 2013-11-23 | BENDAMUSTINE | N | N | 260028361 | RITUXIMAB |
| 260008667 | 260005762 | 1.89 | 85.7 | Curative (C) | 2017-03-13 | 2017-08-23 | EP 1 2 or 3 day | N | N | 260028361 | CISPLATIN + ETOPOSIDE |
| 260008668 | 260005763 | 1.73 | 79 | Palliative (P) | 2013-03-28 | 2013-11-01 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 260028370 | TRIAL |
| 260008669 | 260005763 | null | 56.9 | Curative (C) | 2013-09-29 | 2013-10-05 | GALLIUM TRIAL | 2 | N | 260028370 | RITUXIMAB |
| 260008670 | 260005763 | null | null | Palliative (P) | 2013-05-05 | 2013-05-11 | CHLORAMBUCIL + RITUXIMAB | 02 | N | 260028370 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 260008671 | 260005764 | 1.81 | 82.4 | Palliative (P) | 2015-08-22 | 2015-08-26 | Bendamustine +/- Prednisolone | N | N | 260028375 | CHLORAMBUCIL + RITUXIMAB |
| 260008672 | 260005764 | 1.55 | 78.2 | Disease modification (D) | 2013-09-15 | 2013-09-27 | Rituximab | 02 | N | 260028375 | PACIFICO TRIAL |
| 260008673 | 260005765 | 1.59 | 93 | Palliative (P) | 2016-02-29 | 2016-03-07 | CYCLO + RITUXIMAB + VINCRISTINE | N | N | 260028377 | ICE-R |
| 260008674 | 260005765 | 1.7 | 64 | null | 2016-11-09 | 2016-11-10 | Rituximab | N | N | 260028377 | RITUXIMAB |
| 260008675 | 260005765 | null | 66 | Palliative (P) | null | 2015-12-19 | Cisplatin + Etoposide (5 day) | N | N | 260028377 | CYTARABINE HIGH DOSE |
| 260008676 | 260005765 | null | 76 | Palliative (P) | null | 2016-01-05 | Rituximab | N | null | 260028377 | CHOP R + METHOTREXATE |
| 260008677 | 260005765 | 0 | 78 | Curative (C) | 2016-12-09 | 2017-01-04 | Rituximab | 01 | N | 260028377 | IVE-R |
| 260008678 | 260005766 | 1.87 | null | Curative (C) | 2017-12-27 | 2018-01-16 | Cisplatin | N | N | 260028389 | CISPLATIN + ETOPOSIDE |
| 260008679 | 260005766 | 1.73 | null | Neo-adjuvant (N) | 2017-01-05 | 2017-01-21 | Rituximab | 02 | N | 260028389 | RITUXIMAB |